Epikart Pharma Private Limited
About Epikart Pharma Private Limited
Data last updated:
Epikart Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 21 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24233KA2016PTC085427. Its GSTIN is 37AAECE1700A1ZG (Andhra Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gopavarapu Pavankumar and Segu Srilakshmi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.8 Sonnathamanahalli 2nd Main 2nd Cross R.M Nagar, Bangalore, Karnataka, India – 560036.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.22 Lakh, a growth of 120% compared to the previous year. For the same year it recorded a net loss of ₹19,153 (net margin -1.7%) and EBITDA of ₹1,692 (EBITDA margin 0.2%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years and 24% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo.8 Sonnathamanahalli 2nd Main 2nd Cross R.M Nagar, Bangalore, Karnataka, India – 560036
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Epikart Pharma Private Limited
The main business activity of Epikart Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Epikart Pharma Private Limited FY 2024 filings available
Epikart Pharma Private Limited reported revenue of ₹11.22 Lakh (up 120% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Epikart Pharma Private Limited
Revenue rose 120% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 24%. EBITDA rose 102% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Epikart Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1,692 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹19,153 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Epikart Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -1.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Epikart Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Epikart Pharma Private Limited
Epikart Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Saidatta Farmers Producer Company Limited | ₹11.23 Lakh (FY 2023) | •••• | •••• | •••• | Osmanabad, Maharashtra, India | |
| Znclue Pharma Private Limited | ₹11.23 Lakh (FY 2025) | •••• | •••• | -18.0% | •••• | New Delhi, Delhi, India |
| Ashr Datatech Private Limited | ₹11.22 Lakh (FY 2025) | •••• | •••• | 525.0% | •••• | Chennai, Tamil Nadu, India |
| Hartex International Private Limited | ₹11.22 Lakh (FY 2025) | •••• | •••• | 21.0% | •••• | Hyderabad, Telangana, India |
| Apray Pharma Private Limited | ₹11.22 Lakh (FY 2025) | •••• | •••• | 21.0% | •••• | Meerut, Uttar Pradesh, India |
| Epikart Pharma Private Limited this company | ₹11.22 Lakh (FY 2024) | •••• | •••• | 120.0% | •••• | Bangalore, Karnataka, India |
| Staylife Pharma Private Limited | ₹11.22 Lakh (FY 2024) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Hexorp Industries Private Limited | ₹11.22 Lakh (FY 2024) | •••• | •••• | 352.0% | •••• | Nainital, Uttarakhand, India |
| Luso Iberia Perfumes Private Limited (OPC) | ₹11.22 Lakh (FY 2024) | •••• | •••• | -92.0% | •••• | Bengaluru, Karnataka, India |
| Giriraj Vanijya Private Limited | ₹11.22 Lakh (FY 2025) | •••• | •••• | -4.0% | •••• | Kolkata, West Bengal, India |
| Carolina Fabrics Pvt Ltd | ₹11.22 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Epikart Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Epikart Pharma Private Limited
Epikart Pharma has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gopavarapu Pavankumar | Director | 22 Jan 2016 | 10 Years 8 Months | Current |
| Segu Srilakshmi | Additional Director | 24 Feb 2024 | 2 Years 7 Months | Current |
Ownership and Shareholding of Epikart Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Epikart Pharma Private Limited
Epikart Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Epikart Pharma Private Limited
Employment history and EPFO contributions of people linked to Epikart Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Epikart Pharma Private Limited
Epikart Pharma Private Limited has 8 board changes on record since 2016: 2 appointments and 6 cessations. The latest: Segu Srilakshmi was appointed as Additional Director on 24 Feb 2024.
Credit Ratings, Litigation & Regulatory Alerts for Epikart Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Epikart Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Epikart Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Epikart Pharma Private Limited
Epikart Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAECE1700A1ZG | Andhra Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Epikart Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epikart Pharma Private Limited
Epikart Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in wholesale, within the trading industry. It was incorporated on 21 January 2016 (10+ years old) and is registered under CIN U24233KA2016PTC085427.
Epikart Pharma reported revenue of ₹11.22 Lakh for FY 2024 (up 120% YoY).
Epikart Pharma has 2 current directors:
- Gopavarapu Pavankumar - Director
- Segu Srilakshmi - Additional Director
Epikart Pharma reported a net loss of ₹19,153 (net margin -1.7%) and EBITDA of ₹1,692 (EBITDA margin 0.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Epikart Pharma is -18% over three years and -24% over five years. In the latest year (FY 2024) revenue rose 120%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Epikart Pharma is 37AAECE1700A1ZG, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Epikart Pharma is U24233KA2016PTC085427. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Epikart Pharma was incorporated on 21 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Epikart Pharma by revenue are Saidatta Farmers Producer Company Limited, Znclue Pharma Private Limited, Ashr Datatech Private Limited, Hartex International Private Limited, Apray Pharma Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Segu Srilakshmi was appointed as Additional Director on 24 Feb 2024. Srinivasa Rao Malepati ceased to be Director on 24 Feb 2024. Venunadha Rao Malepati ceased to be Director on 24 Feb 2024. Epikart Pharma has 8 board changes on record in total.
The registered office of Epikart Pharma is at No.8 Sonnathamanahalli 2nd Main 2nd Cross R.M Nagar, Bangalore, Karnataka, India – 560036.